Annual EBITDA
-$170.22 M
+$4.02 M+2.31%
31 December 2023
Summary:
Rhythm Pharmaceuticals annual earnings before interest, taxes, depreciation & amortization is currently -$170.22 million, with the most recent change of +$4.02 million (+2.31%) on 31 December 2023. During the last 3 years, it has fallen by -$36.92 million (-27.69%). RYTM annual EBITDA is now -1509.97% below its all-time high of -$10.57 million, reached on 31 December 2015.RYTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBITDA
-$38.36 M
-$11.57 M-43.19%
30 September 2024
Summary:
Rhythm Pharmaceuticals quarterly earnings before interest, taxes, depreciation & amortization is currently -$38.36 million, with the most recent change of -$11.57 million (-43.19%) on 30 September 2024. Over the past year, it has increased by +$1.85 million (+4.59%). RYTM quarterly EBITDA is now -505.49% below its all-time high of -$6.33 million, reached on 31 March 2017.RYTM Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBITDA
-$237.53 M
+$1.85 M+0.77%
30 September 2024
Summary:
Rhythm Pharmaceuticals TTM earnings before interest, taxes, depreciation & amortization is currently -$237.53 million, with the most recent change of +$1.85 million (+0.77%) on 30 September 2024. Over the past year, it has dropped by -$66.67 million (-39.02%). RYTM TTM EBITDA is now -3643.56% below its all-time high of -$6.34 million, reached on 30 September 2016.RYTM TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RYTM EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +2.3% | +4.6% | -39.0% |
| 3 y3 years | -27.7% | +12.4% | -57.9% |
| 5 y5 years | -118.3% | -3.9% | -72.0% |
RYTM EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -148.7% | +2.3% | -43.2% | +71.8% | -57.9% | +7.0% |
| 5 y | 5 years | -148.7% | +2.3% | -43.2% | +71.8% | -79.4% | +7.0% |
| alltime | all time | -1510.0% | +2.3% | -505.5% | +71.8% | -3643.6% | +7.0% |
Rhythm Pharmaceuticals EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$38.36 M(+43.2%) | -$237.53 M(-0.8%) |
| June 2024 | - | -$26.79 M(-80.3%) | -$239.38 M(-6.3%) |
| Mar 2024 | - | -$135.91 M(+272.7%) | -$255.54 M(+51.8%) |
| Dec 2023 | -$170.22 M(-2.3%) | -$36.47 M(-9.3%) | -$168.29 M(-1.5%) |
| Sept 2023 | - | -$40.20 M(-6.4%) | -$170.86 M(+1.1%) |
| June 2023 | - | -$42.96 M(-11.7%) | -$168.93 M(-0.9%) |
| Mar 2023 | - | -$48.66 M(+24.6%) | -$170.49 M(-2.2%) |
| Dec 2022 | -$174.25 M(+154.5%) | -$39.04 M(+2.0%) | -$174.25 M(-6.2%) |
| Sept 2022 | - | -$38.27 M(-14.0%) | -$185.74 M(-2.9%) |
| June 2022 | - | -$44.52 M(-15.1%) | -$191.25 M(+2.4%) |
| Mar 2022 | - | -$52.41 M(+3.7%) | -$186.85 M(+10.8%) |
| Dec 2021 | -$68.45 M(-48.6%) | -$50.53 M(+15.4%) | -$168.63 M(+12.1%) |
| Sept 2021 | - | -$43.79 M(+9.2%) | -$150.41 M(+6.9%) |
| June 2021 | - | -$40.12 M(+17.3%) | -$140.74 M(+6.3%) |
| Mar 2021 | - | -$34.20 M(+5.8%) | -$132.37 M(-0.7%) |
| Dec 2020 | -$133.31 M | -$32.32 M(-5.3%) | -$133.31 M(-1.3%) |
| Sept 2020 | - | -$34.11 M(+7.5%) | -$135.02 M(-2.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2020 | - | -$31.75 M(-9.6%) | -$137.83 M(-8.1%) |
| Mar 2020 | - | -$35.13 M(+3.2%) | -$150.02 M(+3.3%) |
| Dec 2019 | -$145.17 M(+86.2%) | -$34.03 M(-7.8%) | -$145.17 M(+5.1%) |
| Sept 2019 | - | -$36.92 M(-16.0%) | -$138.07 M(+14.8%) |
| June 2019 | - | -$43.94 M(+45.1%) | -$120.29 M(+31.7%) |
| Mar 2019 | - | -$30.27 M(+12.4%) | -$91.31 M(+17.1%) |
| Dec 2018 | -$77.97 M(+142.2%) | -$26.94 M(+40.8%) | -$77.97 M(+25.8%) |
| Sept 2018 | - | -$19.14 M(+27.9%) | -$61.96 M(+21.4%) |
| June 2018 | - | -$14.96 M(-11.7%) | -$51.05 M(+19.3%) |
| Mar 2018 | - | -$16.94 M(+55.1%) | -$42.79 M(+32.9%) |
| Dec 2017 | -$32.19 M(+25.0%) | -$10.92 M(+32.7%) | -$32.19 M(+8.8%) |
| Sept 2017 | - | -$8.23 M(+22.9%) | -$29.59 M(+6.8%) |
| June 2017 | - | -$6.70 M(+5.8%) | -$27.70 M(+31.9%) |
| Mar 2017 | - | -$6.33 M(-23.9%) | -$21.00 M(+43.2%) |
| Dec 2016 | -$25.76 M(+143.6%) | -$8.32 M(+31.1%) | -$14.66 M(+131.1%) |
| Sept 2016 | - | -$6.34 M | -$6.34 M |
| Dec 2015 | -$10.57 M | - | - |
FAQ
- What is Rhythm Pharmaceuticals annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for Rhythm Pharmaceuticals?
- What is Rhythm Pharmaceuticals annual EBITDA year-on-year change?
- What is Rhythm Pharmaceuticals quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for Rhythm Pharmaceuticals?
- What is Rhythm Pharmaceuticals quarterly EBITDA year-on-year change?
- What is Rhythm Pharmaceuticals TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for Rhythm Pharmaceuticals?
- What is Rhythm Pharmaceuticals TTM EBITDA year-on-year change?
What is Rhythm Pharmaceuticals annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of RYTM is -$170.22 M
What is the all time high annual EBITDA for Rhythm Pharmaceuticals?
Rhythm Pharmaceuticals all-time high annual earnings before interest, taxes, depreciation & amortization is -$10.57 M
What is Rhythm Pharmaceuticals annual EBITDA year-on-year change?
Over the past year, RYTM annual earnings before interest, taxes, depreciation & amortization has changed by +$4.02 M (+2.31%)
What is Rhythm Pharmaceuticals quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of RYTM is -$38.36 M
What is the all time high quarterly EBITDA for Rhythm Pharmaceuticals?
Rhythm Pharmaceuticals all-time high quarterly earnings before interest, taxes, depreciation & amortization is -$6.33 M
What is Rhythm Pharmaceuticals quarterly EBITDA year-on-year change?
Over the past year, RYTM quarterly earnings before interest, taxes, depreciation & amortization has changed by +$1.85 M (+4.59%)
What is Rhythm Pharmaceuticals TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of RYTM is -$237.53 M
What is the all time high TTM EBITDA for Rhythm Pharmaceuticals?
Rhythm Pharmaceuticals all-time high TTM earnings before interest, taxes, depreciation & amortization is -$6.34 M
What is Rhythm Pharmaceuticals TTM EBITDA year-on-year change?
Over the past year, RYTM TTM earnings before interest, taxes, depreciation & amortization has changed by -$66.67 M (-39.02%)